A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase

被引：56

作者：

Bertolacci, Laura ^{[1
]}

Romeo, Elisa ^{[1
]}

Veronesi, Marina ^{[1
]}

Magotti, Paola ^{[1
]}

Albani, Clara ^{[1
]}

Dionisi, Mauro ^{[1
]}

Lambruschini, Chiara ^{[1
]}

Scarpelli, Rita ^{[1
]}

Cavalli, Andrea ^{[2
]}

De Vivo, Marco ^{[1
]}

Piomelli, Daniele ^{[1
,3
]}

Garau, Gianpiero ^{[1
]}

机构：

[1] Ist Italiano Tecnol, I-16163 Genoa, Italy

[2] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy

[3] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA

来源：

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 135卷 / 01期

关键词：

ALPHA-KETOHETEROCYCLE INHIBITORS; SELECTIVE FAAH INHIBITOR; PAIN INITIATION; CYCLOOXYGENASE; ENZYME; INDOMETHACIN; DISCOVERY; ENDOCANNABINOIDS; PROSTAGLANDINS; INFLAMMATION;

D O I：

10.1021/ja308733u

中图分类号：

O6 [化学];

学科分类号：

070301 [无机化学];

摘要：

In addition to inhibiting the cyclooxygenase (COX)-mediated biosynthesis of prostanoids, various widely used nonsteroidal anti-inflammatory drugs (NSAIDs) enhance endocannabinoid signaling by blocking the anandamide-degrading membrane enzyme fatty acid amide hydrolase (FAAH). The X-ray structure of FAAH in complex with the NSAID carprofen, along with site-directed mutagenesis, enzyme activity assays, and NMR analysis, has revealed the molecular details of this interaction, providing information that may guide the design of dual FAAH COX inhibitors with superior analgesic efficacy.

引用

收藏

页码：22 / 25

页数：4

相关论文

共 44 条

[31]

Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH) [J].

Min, Xiaoshan ;

Thibault, Stephen T. ;

Porter, Amy C. ;

Gustin, Darin J. ;

Carlson, Timothy J. ;

Xu, Haoda ;

Lindstrom, Michelle ;

Xu, Guifen ;

Uyeda, Craig ;

Ma, Zhihua ;

Li, Yihong ;

Kayser, Frank ;

Walker, Nigel P. C. ;

Wang, Zhulun .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (18) :7379-7384

[32]

Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors:: Synthesis, quantitative structure-activity relationships, and molecular modeling studies [J].

Mor, M ;

Rivara, S ;

Lodola, A ;

Plazzi, PV ;

Tarzia, G ;

Duranti, A ;

Tontini, A ;

Piersanti, G ;

Kathuria, S ;

Piomelli, D .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) :4998-5008

[33]

Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception [J].

Naidu, Pattipati S. ;

Booker, Lamont ;

Cravatt, Benjamin F. ;

Lichtman, Aron H. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01) :48-56

[34]

NON-STEROIDAL ANALGESIC AND ANTI-INFLAMMATORY AGENTS [J].

NUKI, G .

BRITISH MEDICAL JOURNAL, 1983, 287 (6384) :39-43

[35]

The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH) [J].

Otrubova, Katerina ;

Ezzili, Cyrine ;

Boger, Dale L. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) :4674-4685

[36]

Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse [J].

Palmer, J. A. ;

Higuera, E. S. ;

Chang, L. ;

Chaplan, S. R. .

NEUROSCIENCE, 2008, 154 (04) :1554-1561

[37]

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 [J].

Pertwee, R. G. ;

Howlett, A. C. ;

Abood, M. E. ;

Alexander, S. P. H. ;

Di Marzo, V. ;

Elphick, M. R. ;

Greasley, P. J. ;

Hansen, H. S. ;

Kunos, G. ;

Mackie, K. ;

Mechoulam, R. ;

Ross, R. A. .

PHARMACOLOGICAL REVIEWS, 2010, 62 (04) :588-631

[38]

The molecular logic of endocannabinoid signalling [J].

Piomelli, D .

NATURE REVIEWS NEUROSCIENCE, 2003, 4 (11) :873-884

[39]

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597) [J].

Piomelli, Daniele ;

Tarzia, Giorgio ;

Duranti, Andrea ;

Tontini, Andrea ;

Mor, Marco ;

Compton, Timothy R. ;

Dasse, Olivier ;

Monaghan, Edward P. ;

Parrott, Jeff A. ;

Putman, David .

CNS DRUG REVIEWS, 2006, 12 (01) :21-38

[40]

Effects of cyclooxygenase inhibition on the gastrointestinal tract [J].

Radi, Zaher A. ;

Khan, Nasir K. .

EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2006, 58 (2-3) :163-173

← 1 2 3 4 5 →